Haleon (HLN) Capital Expenditures (2021 - 2025)
Haleon's (HLN) quarterly Capital Expenditures came in at -$128.6 million in Q4 2025, up 15.06% on a QoQ basis from -$151.4 million in Q4 2023.
Haleon (HLN) Capital Expenditures (2021 - 2025) Analysis & Trends
Haleon (HLN) has 4 years of Capital Expenditures data on file, last reported at -$128.6 million in Q4 2025.
- Quarterly Capital Expenditures changed N/A year-over-year to -$128.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$467.6 million (changed N/A YoY) and the FY2025 annual result came in at $428.3 million, up 34.03% from the prior year.
- Capital Expenditures advanced to -$128.6 million in Q4 2025, from -$151.4 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of -$91.5 million in Q4 2022 to a low of -$151.4 million in Q4 2023.
- A 4-year average of -$117.5 million and a median of -$120.0 million in 2021 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures rose 23.74% — and 2023, when it plunged 65.51%.
- Tracing HLN's Capital Expenditures over 4 years: stood at -$120.0 million in 2021, then climbed by 23.74% to -$91.5 million in 2022, then sank by 65.51% to -$151.4 million in 2023, then climbed by 15.06% to -$128.6 million in 2025.
- The last three Capital Expenditures figures came in at -$128.6 million (Q4 2025), -$151.4 million (Q4 2023), and -$91.5 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 8.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -128.62 Mn |
| Dec 31, 2025 | -128.62 Mn |
| Dec 31, 2023 | -151.42 Mn |
| Dec 31, 2023 | -151.42 Mn |
| Dec 31, 2022 | -91.49 Mn |
| Dec 31, 2022 | -91.49 Mn |
| Sep 20, 2022 | -96.04 Mn |
| Sep 20, 2022 | -96.04 Mn |
| Dec 31, 2021 | -119.97 Mn |
| Dec 31, 2021 | -119.97 Mn |